Understanding Follicular Lymphoma Grades: A Guide for Patients

What is Follicular Lymphoma?

Follicular lymphoma (FL) is a type of non-Hodgkin’s lymphoma (NHL) that develops in B cells, a kind of white blood cell responsible for producing antibodies. It accounts for about 30% of all NHL cases. While it is a type of cancer, it is often slow-growing. The outlook for individuals diagnosed with FL is generally good, with about 90% of people living at least 5 years after diagnosis, comparable to those without the condition. However, understanding the 'grade' of follicular lymphoma is crucial as it helps doctors predict how the cancer might behave and how it should be treated.

How Doctors Grade Follicular Lymphoma

The World Health Organization (WHO) grading system is used to classify follicular lymphoma. This system divides FL into three grades (1, 2, and 3) based on how the cancer cells appear under a microscope. Specifically, doctors examine a sample of the lymphoma cells to count the number of large B cells, called centroblasts, within a specific area. The number of these larger cells is a key indicator of how quickly the lymphoma might grow and its potential to transform into a more aggressive form of lymphoma.

Grade 1 Follicular Lymphoma

Grade 1 follicular lymphoma is considered the least aggressive form. It is also sometimes referred to as follicular small cleaved cell lymphoma. Doctors diagnose Grade 1 FL when they observe 0 to 5 centroblasts per high power field (HPF) under the microscope. An HPF is the area visible when looking through the microscope at 400 times magnification.

Grade 2 Follicular Lymphoma

Grade 2 follicular lymphoma is slightly more aggressive than Grade 1. It is characterized by the presence of 6 to 12 centroblasts per HPF. Like Grade 1, Grade 2 FL is generally considered slow-growing.

Grade 3 Follicular Lymphoma

Grade 3 follicular lymphoma is the most aggressive of the three grades. It is further divided into two subtypes:

• Grade 3A: This subtype has 13 to 25 centroblasts per HPF.
• Grade 3B: This subtype has more than 25 centroblasts per HPF, or the presence of large B cells that form sheets. Grade 3B is treated more aggressively than Grade 3A.

It's important to note that about 25% to 35% of follicular lymphoma cases can progress to a more aggressive type of non-Hodgkin’s lymphoma, such as diffuse large B-cell lymphoma (DLBCL). The presence of more centroblasts is associated with a faster progression and a higher chance of this transformation.

Grading vs. Staging for Follicular Lymphoma

It is essential to understand the difference between the 'grade' and the 'stage' of cancer. While the grade measures how aggressive the cancer is predicted to be based on cell appearance, the stage describes how far the cancer has spread in the body. Follicular lymphoma is typically staged using the Lugano classification, which is based on the older Ann Arbor system and divides cancer into four stages.

Symptoms of Follicular Lymphoma

Many people with follicular lymphoma, especially in its early stages, may not experience any noticeable symptoms. When symptoms do occur, they can include:

• Painless swelling of lymph nodes, often in the neck, armpits, or groin, which may enlarge over weeks to months.
• Systemic 'B symptoms', which are general symptoms of illness that can include:
• Fever
• Unexplained weight loss
• Drenching night sweats
• Other less common symptoms can include fatigue, itching, and increased susceptibility to infections.

Diagnosis of Follicular Lymphoma

Diagnosing follicular lymphoma involves several steps:

1. Physical Examination: Doctors will check for swollen lymph nodes and other physical signs.
2. Blood Tests: These can help assess overall health and check for markers like elevated lactate dehydrogenase (LDH), an enzyme found in most body tissues, which can sometimes be higher in lymphoma patients.
3. Biopsy: This is the most crucial diagnostic step. A sample of an enlarged lymph node or other affected tissue is removed and examined under a microscope by a pathologist. This examination determines the type of lymphoma, its grade (as described above), and helps in staging.
4. Imaging Tests: Tests like CT scans, PET scans, or MRIs may be used to determine the stage of the lymphoma by showing if and where it has spread in the body.

Treatment for Follicular Lymphoma

The treatment approach for follicular lymphoma depends heavily on its grade, stage, and whether it is causing symptoms. For slow-growing grades (Grade 1 and 2) that are not causing significant symptoms, doctors may recommend a strategy called 'watch and wait', where the condition is closely monitored without immediate treatment.

When treatment is necessary, options may include:

• Radiation Therapy: Often used for localized disease (early stages).
• Chemotherapy: Used for more advanced stages or symptomatic disease.
• Immunotherapy: Medications like anti-CD20 antibodies (e.g., rituximab) are commonly used, often in combination with chemotherapy. These drugs target specific proteins on lymphoma cells.
• Targeted Therapy: Newer drugs that target specific molecular pathways in cancer cells.

Treatments can help relieve symptoms associated with low blood counts, such as fatigue or increased risk of infection.

Prognosis and Outlook

The prognosis for follicular lymphoma is generally favorable, especially for Grades 1 and 2. Factors linked to a better outlook include:

• Having the lymphoma confined to lymph nodes or only one area outside the lymph nodes.
• Being able to perform daily activities without significant limitations.
• Having normal lactate dehydrogenase (LDH) levels.

As mentioned, the 5-year survival rate is high, indicating that many individuals can live long and fulfilling lives with this condition.

When to Consult a Doctor

It is advisable to consult a doctor if you notice any of the following:

• Painless lumps or swelling in your neck, armpits, or groin.
• Unexplained fever, significant weight loss, or drenching night sweats.
• Persistent fatigue or unusual bruising.
• Any other concerning or persistent symptoms.

Early detection and understanding of the lymphoma's grade and stage are key to effective management and a positive outlook.

Additional Medical Guidance

This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.

Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.

Quick Checklist

• Track symptoms and duration.

• Follow diagnosis and treatment from a licensed practitioner.

• Review medication side effects with your doctor.

• Seek urgent care for severe warning signs.